households are being impacted by some member of that family on GLP-1s
They degrade through aggregation (clumping), oxidation, and deamidation (loss of amide groups)
Lilly, for its part, has published ACHIEVE-3 data showing that orforglipron at its highest dose outperformed oral semaglutide 14 mg on both A1C reduction and weight loss in adults with type 2 diabetes, though this comparison involved the Rybelsus-equivalent doses rather than the obesity-approved dose levels
For body recomposition, the combination of a GH secretagogue with AOD 9604, a fragment of human growth hormone that drives lipolysis through beta-3 adrenergic receptors without affecting muscle anabolism, is worth considering for patients whose primary concern is concurrent fat loss and muscle preservation
The "Nutrient Gap": As adoption of these drugs continues to accelerate, brands that solve the "nutrient gap" problem are onto a winner